81 related articles for article (PubMed ID: 9343933)
1. O-acetyl sialic acid binding lectin as a probe for detection of subtle change on cell surface induced during acute lymphoblastic leukemia (ALL) and its clinical application.
Mandal C; Sinha D; Sharma V; Bhattacharya DK
Indian J Biochem Biophys; 1997; 34(1-2):82-6. PubMed ID: 9343933
[TBL] [Abstract][Full Text] [Related]
2. Increased interferon gamma production by peripheral blood mononuclear cells in response to stimulation of overexpressed disease-specific 9-O-acetylated sialoglycoconjugates in children suffering from acute lymphoblastic leukaemia.
Ghosh S; Bandyopadhyay S; Pal S; Das B; Bhattacharya DK; Mandal C
Br J Haematol; 2005 Jan; 128(1):35-41. PubMed ID: 15606547
[TBL] [Abstract][Full Text] [Related]
3. O-acetylated sialic acid as a distinct marker for differentiation between several leukemia erythrocytes.
Sen G; Chowdhury M; Mandal C
Mol Cell Biochem; 1994 Jul; 136(1):65-70. PubMed ID: 7854333
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of 9-O-acetylated sialoglycoproteins from leukemic cells and their potential as immunological tool for monitoring childhood acute lymphoblastic leukemia.
Pal S; Ghosh S; Mandal C; Kohla G; Brossmer R; Isecke R; Merling A; Schauer R; Schwartz-Albiez R; Bhattacharya DK; Mandal C
Glycobiology; 2004 Oct; 14(10):859-70. PubMed ID: 15190007
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of differential expression of sialic acids and adhesion molecules on mononuclear cells of bone marrow and peripheral blood in childhood acute lymphoblastic leukaemia at diagnosis and clinical remission.
Chowdhury S; Bandyopadhyay S; Chandra S; Mandal C
Indian J Biochem Biophys; 2007 Oct; 44(5):357-65. PubMed ID: 18341211
[TBL] [Abstract][Full Text] [Related]
6. A colorimetric assay to evaluate the chemotherapeutic response of children with acute lymphoblastic leukemia (ALL) employing achatininH: a 9-O-acetyl sialic acid binding lectin.
Sinha D; Bhattacharya DK; Mandal C
Leuk Res; 1999 Sep; 23(9):803-9. PubMed ID: 10475619
[TBL] [Abstract][Full Text] [Related]
7. Interferon gamma promotes survival of lymphoblasts overexpressing 9-O-acetylated sialoglycoconjugates in childhood acute lymphoblastic leukaemia (ALL).
Ghosh S; Bandyopadhyay S; Mallick A; Pal S; Vlasak R; Bhattacharya DK; Mandal C
J Cell Biochem; 2005 May; 95(1):206-16. PubMed ID: 15770663
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of 9-O-acetylated sialoglycoconjugates on leukemic blasts: a potential tool for long-term monitoring of children with acute lymphoblastic leukemia.
Pal S; Ghosh S; Bandyopadhyay S; Mandal C; Bandhyopadhyay S; Kumar Bhattacharya D; Mandal C
Int J Cancer; 2004 Aug; 111(2):270-7. PubMed ID: 15197782
[TBL] [Abstract][Full Text] [Related]
9. Detection of immune-complexed 9-O-acetylated sialoglycoconjugates in the sera of patients with pediatric acute lymphoblastic leukemia.
Bandyopadhyay S; Mukherjee K; Chatterjee M; Bhattacharya DK; Mandal C
J Immunol Methods; 2005 Feb; 297(1-2):13-26. PubMed ID: 15777927
[TBL] [Abstract][Full Text] [Related]
10. Regulation of O-acetylation of sialic acids by sialate-O-acetyltransferase and sialate-O-acetylesterase activities in childhood acute lymphoblastic leukemia.
Mandal C; Mandal C; Chandra S; Schauer R; Mandal C
Glycobiology; 2012 Jan; 22(1):70-83. PubMed ID: 21803834
[TBL] [Abstract][Full Text] [Related]
11. Altered erythrocyte membrane characteristics during anemia in childhood acute lymphoblastic leukemia.
Ghosh S; Bandyopadhyay S; Bhattacharya DK; Mandal C
Ann Hematol; 2005 Feb; 84(2):76-84. PubMed ID: 15338196
[TBL] [Abstract][Full Text] [Related]
12. Antibodies against 9-O-acetylated sialic acids in childhood acute lymphoblastic leukemia: a two-year study with 186 samples following protocol MCP 943.
Bandyopadhyay S; Chatterjee M; Banavali SD; Pal S; Nair CN; Advani SH; Mandal C
Indian J Biochem Biophys; 2006 Feb; 43(1):7-14. PubMed ID: 16955745
[TBL] [Abstract][Full Text] [Related]
13. Over-expressed IgG2 antibodies against O-acetylated sialoglycoconjugates incapable of proper effector functioning in childhood acute lymphoblastic leukemia.
Bandyopadhyay S; Bhattacharyya A; Mallick A; Sen AK; Tripathi G; Das T; Sa G; Bhattacharya DK; Mandal C
Int Immunol; 2005 Feb; 17(2):177-91. PubMed ID: 15629900
[TBL] [Abstract][Full Text] [Related]
14. Co-expression of 9-O-acetylated sialoglycoproteins and their binding proteins on lymphoblasts of childhood acute lymphoblastic leukemia: an anti-apoptotic role.
Mukherjee K; Chava AK; Bandyopadhyay S; Mallick A; Chandra S; Mandal C
Biol Chem; 2009 Apr; 390(4):325-35. PubMed ID: 19166321
[TBL] [Abstract][Full Text] [Related]
15. O-acetylated sialic acids: multifaceted role in childhood acute lymphoblastic leukaemia.
Chowdhury S; Mandal C
Biotechnol J; 2009 Mar; 4(3):361-74. PubMed ID: 19296441
[TBL] [Abstract][Full Text] [Related]
16. Identification of 9-O acetyl sialoglycoconjugates (9-OAcSGs) as biomarkers in childhood acute lymphoblastic leukemia using a lectin, AchatininH, as a probe.
Sinha D; Mandal C; Bhattacharya DK
Leukemia; 1999 Jan; 13(1):119-25. PubMed ID: 10049046
[TBL] [Abstract][Full Text] [Related]
17. [Leukocyte glucocorticoid receptor and its mRNA levels in leukemia patients].
Dong Q; Meng P; Min B
Zhonghua Xue Ye Xue Za Zhi; 1999 May; 20(5):252-4. PubMed ID: 11601215
[TBL] [Abstract][Full Text] [Related]
18. Follow-up of minimal residual disease in acute childhood lymphoblastic leukemia by WT1 gene expression in the peripheral blood: the Hungarian experience.
Magyarosy E; Varga N; Timár J; Rásó E
Pediatr Hematol Oncol; 2003; 20(1):65-74. PubMed ID: 12687755
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of adsorbed serum sialoglycans on Leishmania donovani promastigotes.
Chatterjee M; Chava AK; Kohla G; Pal S; Merling A; Hinderlich S; Unger U; Strasser P; Gerwig GJ; Kamerling JP; Vlasak R; Crocker PR; Schauer R; Schwartz-Albiez R; Mandal C
Glycobiology; 2003 May; 13(5):351-61. PubMed ID: 12626423
[TBL] [Abstract][Full Text] [Related]
20. Myeloid antigens in childhood lymphoblastic leukemia: clinical data point to regulation of CD66c distinct from other myeloid antigens.
Kalina T; Vaskova M; Mejstrikova E; Madzo J; Trka J; Stary J; Hrusak O
BMC Cancer; 2005 Apr; 5():38. PubMed ID: 15826304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
